Core Insights - Universal Technical Institute (UTI) is a leading provider of technical education and workforce training in the U.S., focusing on automotive, diesel, and related fields, leveraging industry partnerships and specialized curricula to meet the demand for skilled technicians [1][2] Group 1: Company Overview - UTI serves individuals seeking specialized technical careers, targeting recent high school graduates and adult learners in the transportation and manufacturing sectors [2] - The company operates a campus-based, postsecondary education model, generating revenue primarily from tuition and fees paid by students and manufacturer-sponsored training partnerships [2] Group 2: Financial Performance - UTI generated sales of $220.8 million in its fiscal first quarter ended December 31, up from $201.4 million in the prior year, indicating strong financial growth [8] - The company's share price reached a 52-week high of $39.06 on March 24, 2026, driven by solid financial performance and business developments, including a multi-year agreement with Fuji Spray Auto [7] Group 3: Shareholder Activity - Director George W. Brochick sold 5,000 shares of UTI for approximately $183,000, which represents a 13.6% decline in his total holdings, leaving him with 4,279 shares directly and 27,516 shares indirectly [5][6] - The sale aligns with Brochick's recent selling activity, which has seen a median of 6,000 shares sold across three transactions since February 2025 [4]

Company Overview - Universal Technical Institute (UTI) is a leading provider of technical education, focusing on training for automotive, diesel, and related skilled trades, leveraging a national campus network and partnerships with manufacturers to deliver industry-aligned curricula [6] - As of November 13, 2025, UTI's stock price was $29.38, with a market capitalization of $1.60 billion, revenue of $835.62 million, and net income of $63.02 million [4][10] Financial Performance - UTI ended its 2025 fiscal year with revenue of $835.6 million, reflecting a strong 14% year-over-year increase, while net income rose to $63 million, representing a 50% year-over-year growth [10] - Despite strong fiscal performance, UTI's stock price declined due to anticipated net income drop of about 33% year-over-year for the 2026 fiscal year as the company invests in expanding its business [11] Investment Activity - Needham Investment Management LLC increased its position in UTI by 239,000 shares during the third quarter, raising its total stake to 550,000 shares valued at $17.90 million, a net increase of $7.36 million from the previous quarter [2][3] - The increased stake represents 1.2% of Needham's 13F reportable assets under management (AUM) [3] Market Performance - UTI shares have increased by 44.5% over the past year, outperforming the S&P 500 by 33.3 percentage points [3] - The stock price experienced a decline to a 52-week low of $21.29 in November, despite the company's strong revenue growth [7]